Ochre Bio has appointed Elaine Sullivan as senior independent non-executive director. She joins the Oxford-based RNA therapeutics company with a wealth of experience in global pharma R&D and strategic leadership. Sullivan previously served as vice president of global external R&D at Eli Lilly, where she managed a $100m portfolio, and as vice president at AstraZeneca, […]
The post Ochre Bio appoints Elaine Sullivan as senior independent non-executive director appeared first on Pharmafile.
